FDA proposes oral phenylephrine, found in many decongestants, pulled from shelves
The Food and Drug Administration proposed that oral phenylephrine be removed ... Vicks DayQuil and Mucinex Sinus-Max, CNN reported. The FDA approved phenylephrine in the 1970s but it was used in more products in 2005 after pseudoephedrine was forced ...
FDA moves to pull popular decongestant from shelves amid effectiveness concerns
The US Food and Drug Administration announced a proposal to remove oral phenylephrine – a common ingredient in many popular over-the-counter decongestants – from the market, citing evidence that it doesn’t work.
FDA proposes ending use of popular decongestant in cold medicines
The US Food and Drug Administration has proposed to remove oral phenylephrine, widely used in cold and cough syrups, as an active ingredient in over-the-counter drugs for nasal congestion, stating it is not effective,
FDA says commonly used decongestant 'not effective,' proposes removal
The U.S. Food and Drug Administration has determined commonly used oral phenylephrine is "not effective" and has proposed its removal from over-the-counter nasal decongestants.
FDA to pull common but ineffective cold medicine from market
The FDA says oral phenylephrine, used in many over-the-counter cough and cold medicines, "is not effective as a nasal decongestant."
FDA wants to halt sales of decongestants containing ineffective phenylephrine
Just as cold and flu season arrives, the Food and Drug Administration proposes pulling many decongestants from store shelves. The reason? An administration review found oral phenylephrine — a common ingredient in over-the-counter cold medications — doesn’t work.
FDA wants to remove popular decongestants from stores permanently that contain this ingredient
The Food and Drug Administration says it wants to remove some of the most popular over-the-counter decongestants that have a common ingredient in them.
After decades, FDA finally moves to pull ineffective decongestant off shelves
Specifically, the FDA issued a proposed order to remove oral phenylephrine from the list of drugs that drugmakers can include in over-the-counter products—also known as the OTC monograph. Once removed,
“Pack your bags” RFK Jr. tells FDA. His war on public health under Trump would only accelerate
including as the commissioner of the Food and Drug Administration (FDA). Kennedy, an environmental lawyer with no ...
JD Supra20m
FDA Approves the First Flu Vaccine for At Home Use, Providing a Needle Free Option Outside of Traditional Health Care Settings
On September 20, 2024, the U.S. Food and Drug Administration (FDA) approved the first influenza (flu) vaccine for at‑home use. The vaccine, ...
CBC Online 1380 KCIM8h
FDA seeks to pull common but ineffective OTC cold medicine ingredient off the market
The Food and Drug Administration (“FDA”) said on Thursday that they will seek to pull the common ingredient phenylephrine off ...
Supplement Recalls: FDA Warns of Products With 'Hidden Drug Ingredient'
Two dietary supplements, sold to support men's health, have been recalled due to undeclared "hidden drug ingredients," the U.S. Food and Drug Administration says ... in Viagra—and ...
Barron's on MSN2d
Robert F. Kennedy Jr.’s Views Now Matter for the Nation. Here’s How He Could Influence Food and Drug Policy
Donald Trump has said Robert F. Kennedy Jr. will have a major role overseeing health policy under his new administration. It ...
Quality Assurance22h
FDA and EPA Announce First Registered Pre-Harvest Agricultural Water Treatment
This registration marks the first approval of a treatment for use against foodborne pathogens, such as Salmonella and E. coli ...
Food, fluoride and funding: How a new Trump term might affect health in California
For example, if Kennedy makes changes to the Food and Drug Administration that weakens its ability to ... Mifepristone ...
Business Wire1mon
U.S. Food and Drug Administration (FDA) accepts New Drug Application for elinzanetant
BERLIN--(BUSINESS WIRE)--Bayer today announced that the U.S. Food and Drug Administration (FDA) has accepted the company’s New Drug Application (NDA) for the investigational compound ...
FDA approves a new weight loss drug, Zepbound from Eli Lilly
The medication, tirzepatide, was previously approved as Mounjaro for diabetes and will now be marketed as Zepbound for weight loss.